• FindA University Ltd Featured PhD Programmes
  • University of Glasgow Featured PhD Programmes
  • University of Manchester Featured PhD Programmes
  • University College London Featured PhD Programmes
  • University of Birmingham Featured PhD Programmes
  • UNSW Australia Featured PhD Programmes
  • Heriot-Watt University Featured PhD Programmes
University of Sheffield Featured PhD Programmes
EPSRC Featured PhD Programmes
Imperial College London Featured PhD Programmes
University of Southampton Featured PhD Programmes
University of Bristol Featured PhD Programmes

What role do antibodies play in multiple sclerosis?

This project is no longer listed in the FindAPhD
database and may not be available.

Click here to search the FindAPhD database
for PhD studentship opportunities
  • Full or part time
    Dr J Edgar
    Prof C Linington
  • Application Deadline
    No more applications being accepted
  • Funded PhD Project (European/UK Students Only)
    Funded PhD Project (European/UK Students Only)

Project Description

Medical Research Scotland
PhD Studentship Award

This project is one of 11 four year PhD Studentships funded by Medical Research Scotland (http://www.medicalresearchscotland.org.uk) to be delivered jointly by the named University and Company. The Studentship will provide the first-class academic and commercial training needed to equip the successful candidate for a science career in an increasingly competitive market.

"From diagnosis to function: the pathophysiological significance of intra-thecal antibody responses to lipids in multiple sclerosis." to be delivered by the University of Glasgow [Supervisors: Dr Julia Edgar and Professor Christopher Linington (both Institute of Infection, Immunity and Inflammation)] and EUROIMMUN UK Limited (https://www.euroimmun.com/startseite.html) [Company supervisor: Dr Christian Probst].

This project aims to investigate the pathophysiological significance of intra-thecal synthesis of lipid-specific antibodies in multiple sclerosis (MS). Accumulation of disability in progressive multiple sclerosis (PMS) has been attributed to axonal injury and loss caused by inflammatory mechanisms occurring behind an intact blood brain barrier. The most obvious manifestation of this sequestered response is the presence of oligoclonal bands (OCB) of immunoglobulin (Ig) in cerebrospinal fluid (CSF). This intrathecal antibody response is present in >90% of patients at diagnosis, but despite associations with a more aggressive disease course, its pathophysiological significance remains obscure. The specificity profile (antigen targets) of this intrathecal antibody response is complex and differs between patients; nonetheless, in many patients a significant proportion of these antibodies recognise myelin lipids. Our most recent studies suggest these lipid-specific antibodies contribute to disease development by inducing a complex interferon-α/β receptor-dependent increase in expression of pro-inflammatory chemokines and proliferation of microglia; a combination of effects that provide a logical explanation for reports intrathecal synthesis of lipid-specific antibodies is associated with increased inflammatory activity in the CNS of patients. We believe this effect might be responsible for maintaining an inflammatory milieu in PMS despite the blood-brain barrier being intact. In this project will use neural cell cultures, small animal surgical techniques, immunocytochemistry and molecular methods to validate this hypothesis and develop effective strategies to identify and treat patients at risk.

ENQUIRIES:

Enquiries should be sent by email to Dr Julia Edgar:
[email protected]

APPLICATIONS:

Candidates must have obtained, or expect to obtain, a first or 2.1 UK BSc Honours degree, or equivalent for degrees obtained outside the UK, in relevant discipline.

Applicants should send a CV, the contact details of 2 academic references (including email addresses) and a covering letter, explaining why the applicant wishes to carry out this project, by email to Dr Julia Edgar:
[email protected]

Interviews are expected to take place approximately 4 weeks after the closing date for applications.

It is anticipated that the PhD Studentship will start in September 2017.

Funding Notes

PhD Studentship provides: an annual tax-free stipend of £17,500, increasing to £18,000 over the four years; tuition fees at UK/EU rates only; consumables; and contribution to travel expenses. International fees are not covered.

References

http://www.gla.ac.uk/researchinstitutes/iii/
http://www.gla.ac.uk/researchinstitutes/iii/staff/juliaedgar/#/publications,articles,grants,researchinterests

How good is research at University of Glasgow in Biological Sciences?

FTE Category A staff submitted: 60.34

Research output data provided by the Research Excellence Framework (REF)

Click here to see the results for all UK universities
Share this page:

Cookie Policy    X